Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs

Chem Commun (Camb). 2014 Dec 4;50(93):14498-500. doi: 10.1039/c4cc04280h.

Abstract

The release of azidothymidine from macromolecular prodrugs was designed to respond to the intracellular disulfide reshuffling. This drug has no thiol groups, and a response to this trigger was engineered using a self-immolative linker. The resulting formulations were fast-acting, efficacious, and highly potent with regards to suppressing the infectivity of the virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemistry*
  • Anti-HIV Agents / pharmacology*
  • Cell Line
  • Disulfides / chemistry*
  • Dose-Response Relationship, Drug
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects*
  • Humans
  • Macromolecular Substances / chemistry
  • Macromolecular Substances / pharmacology
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Prodrugs / chemistry*
  • Prodrugs / pharmacology*
  • Structure-Activity Relationship
  • Time Factors
  • Zidovudine / chemistry
  • Zidovudine / pharmacology*

Substances

  • Anti-HIV Agents
  • Disulfides
  • Macromolecular Substances
  • Prodrugs
  • Zidovudine